Novartis analysis shows inclisiran lowers LDL-C with high consistency
The analysis evaluated the efficacy and tolerability of inclisiran on top of a maximally tolerated dose of statins, in two studies…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
AbbVie, Harvard University collaborate for research on emergent viral diseases
AbbVie will provide $30 million over three years
GARDP and Bugworks sign MoU to develop antibiotics for serious bacterial infections
The collaboration includes working together for the preparation of regulatory strategies, in particular for clinical development…
Active ingredient in insect repellent may protect against COVID-19: UK study
Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface
Premas Biotech’s COVID-19 vaccine candidate sees neutralising immune response in animal studies
The company announced that it is in talks with regulatory authorities for human trials of its triple antigen vaccine
Sometimes giants need a shoulder to stand on too
Clarinda Cerejo, VP, Content & Community, CACTUS highlights that it is time to create a more conducive environment for…
Moderna informs COVID-19 vaccine induced immune response in older adults in small study
The latest data from an early Phase I study includes an analysis from 20 additional people detailing how the vaccine performed in…
IIT Guwahati and RIKEN-Japan collaborate for novel approach to separate chiral molecules
The separation of enantiomers is important in the biomedical field because many biochemically active chemicals are found as…
AstraZeneca’s COVID-19 vaccine data may fall short of desirable protection results: GlobalData
The ongoing early study only requires 30 COVID-19 cases to detect vaccine efficacy, which is much too small to be sure of…
Novavax commences Phase 2 clinical trial of COVID-19 vaccine candidate
Trial to enroll up to 1,500 volunteers in the US and Australia, with approximately 50 per cent between 60 and 84 years of age
Common osteoporosis drugs can increase risk of rare fractures
The risk of atypical femur fractures increases with longer bisphosphonate use, especially after five years
Bharat Biotech gets green signal from CDSCO to test COVAXIN via skin
Presently, the vaccine is being tested through the intramuscular route
Remdesivir has only marginal benefit for moderate COVID-19 patients
The 600-patient analysis found that moderately-ill patients treated with Remdesivir for up to five days had significantly higher…
Research links COVID-19 to rise in childhood type 1 diabetes
This study analysed data from 30 children in London hospitals diagnosed with new-onset type 1 diabetes during the first peak of…
INST-Mohali develops oral nano-medicines for Kala-Azar and other neglected diseases
According to the INST team, till-date there is no study reported where a combination of two anti-leishmanial drugs has been…
Researchers develop technology to see inside cells
The new technology may help answer outstanding questions about the immune system, cancer, Alzheimer’s, and more
Pakistan to conduct phase-III clinical trial of COVID-19 vaccine from CanSinoBio
The NIH said this would be the first-ever phase-III clinical trial for any vaccine in Pakistan
CARE consortium launched to fast-track discovery and development of medicines to treat COVID-19
The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies
Scientists ascertain 73 novel variants of COVID-19 strain in Odisha
The research team, which carried out sequencing of 1,536 samples including 752 clinical samples, reported two lineages -- B.1.112…
COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData
The number of trials that have been impacted by slow enrollment has increased by 13.9 per cent